Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
45.83B | 42.79B | 49.60B | 35.41B | 28.98B | 29.76B | Gross Profit |
9.34B | 8.26B | 9.41B | 8.05B | 6.93B | 6.22B | EBIT |
4.54B | 3.59B | 4.62B | 3.48B | 2.66B | 1.87B | EBITDA |
6.32B | 5.50B | 6.67B | 5.18B | 4.32B | 3.54B | Net Income Common Stockholders |
2.94B | 2.38B | 3.23B | 2.54B | 2.00B | 1.38B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.45B | 3.40B | 4.94B | 3.54B | 3.41B | 4.74B | Total Assets |
44.54B | 44.32B | 47.55B | 41.92B | 36.93B | 37.56B | Total Debt |
8.87B | 8.91B | 12.17B | 11.14B | 10.13B | 11.59B | Net Debt |
4.42B | 5.51B | 7.23B | 7.61B | 6.72B | 6.85B | Total Liabilities |
18.75B | 20.06B | 24.30B | 21.62B | 19.21B | 21.81B | Stockholders Equity |
25.79B | 24.97B | 23.13B | 20.21B | 17.65B | 15.70B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.99B | 1.12B | -434.00M | 625.00M | 1.25B | Operating Cash Flow |
0.00 | 4.97B | 2.04B | 2.00B | 2.37B | 2.96B | Investing Cash Flow |
0.00 | -1.89B | -961.00M | -2.32B | -1.86B | -1.41B | Financing Cash Flow |
0.00 | -4.74B | 245.00M | 308.00M | -1.82B | -2.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥163.72B | 10.68 | 5.46% | 0.50% | -8.77% | ||
76 Outperform | €576.89B | 13.36 | 18.55% | 4.30% | 10.88% | 14.80% | |
74 Outperform | $662.19B | 11.31 | 7.04% | 4.80% | 5.74% | 1.14% | |
74 Outperform | ¥255.18B | 14.31 | 6.56% | 4.42% | 61.99% | ||
64 Neutral | ¥28.84B | 9.03 | 3.96% | 9.33% | 45.97% | ||
61 Neutral | ¥171.52B | 15.29 | -4.17% | 5.32% | 2.82% | -202.97% | |
51 Neutral | $2.04B | -1.23 | -21.09% | 3.96% | 2.90% | -30.45% |